Tortoise Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-78
| Closed | -$8.66K | – | 711 |
|
|
2025
Q3 | $8.66K | Buy |
78
+35
| +81% | +$3.98K | ﹤0.01% | 632 |
|
|
2025
Q2 | $4.77K | Buy |
+43
| New | +$4.58K | ﹤0.01% | 665 |
|
|
2024
Q1 | – | Sell |
-45
| Closed | -$3.65K | – | 874 |
|
|
2023
Q4 | $3.65K | Hold |
45
| – | – | ﹤0.01% | 652 |
|
|
2023
Q3 | $3.37K | Hold |
45
| – | – | ﹤0.01% | 653 |
|
|
2023
Q2 | $3.47K | Sell |
45
-200
| -82% | -$16K | ﹤0.01% | 645 |
|
|
2023
Q1 | $20.3K | Hold |
245
| – | – | ﹤0.01% | 457 |
|
|
2022
Q4 | $21K | Hold |
245
| – | – | ﹤0.01% | 448 |
|
|
2022
Q3 | $15K | Hold |
245
| – | – | ﹤0.01% | 480 |
|
|
2022
Q2 | $15K | Sell |
245
-200
| -45% | -$12.4K | ﹤0.01% | 467 |
|
|
2022
Q1 | $26K | Hold |
445
| – | – | ﹤0.01% | 390 |
|
|
2021
Q4 | $32K | Hold |
445
| – | – | 0.01% | 336 |
|
|
2021
Q3 | $31K | Hold |
445
| – | – | 0.01% | 327 |
|
|
2021
Q2 | $31K | Hold |
445
| – | – | 0.01% | 324 |
|
|
2021
Q1 | $29K | Hold |
445
| – | – | 0.01% | 314 |
|
|
2020
Q4 | $26K | Buy |
445
+200
| +82% | +$12.1K | 0.01% | 302 |
|
|
2020
Q3 | $15K | Hold |
245
| – | – | ﹤0.01% | 335 |
|
|
2020
Q2 | $19K | Sell |
245
-420
| -63% | -$32.2K | ﹤0.01% | 305 |
|
|
2020
Q1 | $50K | Buy |
665
+205
| +45% | +$14.2K | 0.01% | 218 |
|
|
2019
Q4 | $30K | Buy |
460
+415
| +922% | +$27K | 0.01% | 280 |
|
|
2019
Q3 | $3K | Sell |
45
-415
| -90% | -$27.1K | ﹤0.01% | 503 |
|
|
2019
Q2 | $31K | Hold |
460
| – | – | 0.01% | 288 |
|
|
2019
Q1 | $30K | Hold |
460
| – | – | 0.01% | 290 |
|
|
2018
Q4 | $29K | Hold |
460
| – | – | 0.01% | 282 |
|
|
2018
Q3 | $36K | Hold |
460
| – | – | 0.01% | 266 |
|
|
2018
Q2 | $33K | Hold |
460
| – | – | 0.01% | 281 |
|
|
2018
Q1 | $35K | Sell |
460
-1,869
| -80% | -$149K | 0.01% | 277 |
|
|
2017
Q4 | $167K | Buy |
2,329
+69
| +3% | +$5.24K | 0.05% | 144 |
|
|
2017
Q3 | $183K | Hold |
2,260
| – | – | 0.06% | 136 |
|
|
2017
Q2 | $160K | Hold |
2,260
| – | – | 0.05% | 132 |
|
|
2017
Q1 | $153K | Hold |
2,260
| – | – | 0.05% | 125 |
|
|
2016
Q4 | $162K | Hold |
2,260
| – | – | 0.06% | 118 |
|
|
2016
Q3 | $179K | Hold |
2,260
| – | – | 0.06% | 107 |
|
|
2016
Q2 | $189K | Hold |
2,260
| – | – | 0.07% | 105 |
|
|
2016
Q1 | $208K | Sell |
2,260
-220
| -9% | -$19.8K | 0.07% | 104 |
|
|
2015
Q4 | $251K | Hold |
2,480
| – | – | 0.09% | 101 |
|
|
2015
Q3 | $244K | Sell |
2,480
-165
| -6% | -$18.3K | 0.09% | 98 |
|
|
2015
Q2 | $310K | Hold |
2,645
| – | – | 0.12% | 90 |
|
|
2015
Q1 | $260K | Sell |
2,645
-51
| -2% | -$5.18K | 0.1% | 92 |
|
|
2014
Q4 | $254K | Sell |
2,696
-119
| -4% | -$12.3K | 0.1% | 89 |
|
|
2014
Q3 | $300K | Sell |
2,815
-425
| -13% | -$41.6K | 0.13% | 84 |
|
|
2014
Q2 | $269K | Buy |
3,240
+1,440
| +80% | +$112K | 0.11% | 87 |
|
|
2014
Q1 | $128K | Hold |
1,800
| – | – | 0.06% | 122 |
|
|
2013
Q4 | $135K | Hold |
1,800
| – | – | 0.07% | 109 |
|
|
2013
Q3 | $113K | Sell |
1,800
-600
| -25% | -$35.9K | 0.07% | 107 |
|
|
2013
Q2 | $123K | Buy |
+2,400
| New | +$125K | 0.08% | 91 |
|
Other funds holding GILD
Tortoise Investment Management's GILD Position: Q4 2025 in Review
Tortoise Investment Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 78 shares — an estimated $8.66K sold.
Tortoise Investment Management first reported a position in GILD in Q2 2013 and held it in 45 quarters. The position peaked at $310K in Q2 2015. 2,219 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Tortoise Investment Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Tortoise Investment Management sold 78 Gilead Sciences shares in Q4 2025, an estimated $8.66K.
- Tortoise Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 45 quarters.
- Tortoise Investment Management's Gilead Sciences position peaked at $310K in Q2 2015.
- 2,219 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.